deltatrials
Active Not Recruiting PHASE2 Interventional 1-arm NCT01586260

Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission

A Phase II Preventative Trial of DFMO as a Single Agent in Patients With High Risk Neuroblastoma in Remission

Sponsor: Beat NB Cancer Foundation

Conditions Neuroblastoma
Interventions DFMO
Updated 9 times since 2017 Last updated: Nov 16, 2020 Started: Jun 30, 2012 Primary completion: Apr 26, 2021 Completion: Apr 26, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Neuroblastoma, this trial is ongoing. The trial is conducted by Beat NB Cancer Foundation and has accumulated 9 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotActive Not Recruiting~Feb 2017 – ~May 2017 · 3 months · monthly snapshotActive Not Recruiting~May 2017 – ~Jun 2018 · 13 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotActive Not Recruiting~Aug 2018 – ~Aug 2019 · 12 months · monthly snapshotActive Not Recruiting~Aug 2019 – ~Apr 2020 · 8 months · monthly snapshotActive Not Recruiting~Apr 2020 – ~Dec 2020 · 8 months · monthly snapshotActive Not Recruiting~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotActive Not Recruiting~Jan 2021 – present · 66 months · monthly snapshotActive Not Recruiting

Change History

9 versions recorded

  1. Jan 2021 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

  3. Apr 2020 — Dec 2020 [monthly]

    Active Not Recruiting PHASE2

  4. Aug 2019 — Apr 2020 [monthly]

    Active Not Recruiting PHASE2

  5. Aug 2018 — Aug 2019 [monthly]

    Active Not Recruiting PHASE2

▶ Show 4 earlier versions

  1. Jun 2018 — Aug 2018 [monthly]

    Active Not Recruiting PHASE2

  2. May 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

  3. Feb 2017 — May 2017 [monthly]

    Active Not Recruiting PHASE2

  4. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Beat NB Cancer Foundation
  • Cancer Prevention Pharmaceuticals, Inc.
  • Giselle SaulnierSholler
  • University of Arizona
  • University of Hawaii
  • University of Vermont
Data source: Atrium Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austin, United States , Boston, United States , Charleston, United States , Charlotte, United States , Dallas, United States , Grand Rapids, United States , Hartford, United States , Hershey, United States , Honolulu, United States , Houston, United States and 8 more locations